ITEMS IN AFP WITH KEYWORD:
Depression and Bipolar Disorder
This study found that sertraline is more effective than placebo (number needed to treat = 6) in preventing the onset of a major depressive disorder in adults following a TBI. This study included patients with mild, moderate, and severe TBI.
In adolescents who eschew drug treatment of major depression, short-term CBT is more effective than treatment as usual in inducing recovery, with a number needed to treat of 4 to 10. CBT also produced faster results.
A.B., a 29-year-old man, presents to your office for a routine visit. He has a history of being overweight and has hypertension that is controlled by diet and exercise.
Aug 15, 2016 Issue
Screening for Depression in Adults: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF recommends screening for depression in the general adult population, including pregnant and postpartum women. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up.
All women should be screened for depression during and shortly after pregnancy, and depression symptoms should be distinguished from normal baby blues. Learn about available screening questionnaires and commonly prescribed antidepressants.
Although new fathers are at lower risk of depression than are new mothers, the prevalence of depression in new fathers is higher than that in the general population.
Mar 15, 2016 Issue
Screening for Depression in Children and Adolescents: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF recommends screening for major depressive disorder (MDD) in adolescents aged 12 to 18 years. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up.
Combined treatment with citalopram plus methylphenidate provided faster improvement of depression symptoms in older patients with unipolar depression. Combined treatment was also more likely than either medication alone to lead to remission of depression at four weeks and 16 weeks.
Levomilnacipran should not be used in patients with mild to moderate depression until studies have proven its effectiveness. It is somewhat effective in patients with moderate to severe depression. The short-term adverse effect profile of levomilnacipran is similar to that of other SNRIs.
Oct 1, 2015 Issue
ACOG Releases Recommendations on Screening for Perinatal Depression [Practice Guidelines]
The American College of Obstetricians and Gynecologists (ACOG) has released recommendations on screening women for perinatal depression, with the purpose of increasing awareness of depression and lessening the effects it has on pregnant and post-partum women and their families.